Veterinary diagnostics company tops ‘Innovation World Cup

FluoretiQ's innovative approach to veterinary diagnostics, with its Veri-5 Vet product, which is designed to identify the most common canine and feline urinary tract infection pathogens directly from urine samples. 

Dr Neciah Dorh, CEO and Co-Founder of FluoretiQ Limited, said, “The Hong Kong MedTech Innovation World Cup win is a major boost for us, and positions FluoretiQ as a leading voice in global MedTech innovation with a mission grounded firmly in improving outcomes for patients, and the clinical professionals who care for them. We are especially honoured to receive this award during the first Wearable Technologies Conference to be hosted in Hong Kong in 10 years.” 

According to Towards Healthcare, the Veterinary diagnostics market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 12.89 billion in 2026 to approximately USD 28.45 billion by 2035, representing a compound annual growth rate (CAGR) of 9.2% from 2026 to 2035. Growth is driven by the increasing number of pet owners, which is leading to higher spending on veterinary care, with continuous innovation in diagnostic technology such as molecular diagnostics and point-of-care testing, enhancing accuracy and efficiency. 

Technological Advancements in Point-of-Care and Molecular Diagnostics 

IDEXX’s SediVue Dx automates urine-sediment microscopy with 96% concordance, slashing technician time per sample from 8 minutes to 2 minutes. Zoetis’ Vetscan Imagyst utilises smartphone cameras and cloud-based AI to detect faecal parasites in under-resourced clinics. Heska’s Element POC blood-gas unit uploads real-time lactate and ionised-calcium values to electronic records, supporting rapid anaesthesia adjustments. 

These innovations decentralise diagnostics, enabling sustained growth in the veterinary diagnostics market. 

Neciah Dorh, chief executive and co-founder of FluoretiQ, said, it is the leading voice in global MedTech innovation with a mission grounded firmly in improving outcomes for animals, their owners, and the veterinary professionals who care for them. 

A recent report by Towards Healthcare highlights that the Veterinary diagnostics market is witnessing growth by the increasing demand for early disease detection, preventive healthcare, and point-of-care testing solutions. Also, by rising pet ownership, increasing livestock populations, expanding veterinary infrastructure, and growing investments in animal healthcare across countries like China.  

North America and the Asia Pacific region are the dominant and fastest-growing segments in the veterinary diagnostics market, with the U.S. being the largest revenue contributor. The Asia Pacific region is also experiencing rapid growth, driven by increasing awareness of zoonotic diseases and rising spending on animal health and wellness.